SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000935836-21-000176
Filing Date
2021-02-16
Accepted
2021-02-16 16:47:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 larimar13ga.htm SC 13G 58628
  Complete submission text file 0000935836-21-000176.txt   60355
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Subject) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88225 | Film No.: 21639973
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OGIER GLOBAL (CAYMAN) LIMITED 89 NEXUS WAY CAMANA BAY E9 KY1-9009
Business Address C/O OGIER GLOBAL (CAYMAN) LIMITED 89 NEXUS WAY CAMANA BAY E9 KY1-9009 (415) 801-4675
Logos Global Master Fund LP (Filed by) CIK: 0001831371 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G